Cargando…
The New Direct Antiviral Agents and Hepatitis C in Thoracic Transplantation: Impact on Donors and Recipients
PURPOSE OF REVIEW: The landscape of abdominal organ transplantation has been altered by the emergence of curative direct-acting antiviral agents for hepatitis C. Expansion of the thoracic donor pool to include the hearts and the lungs from hepatitis C-positive donors holds promise to increase availa...
Autores principales: | Gottlieb, Robert L., Hall, Shelley A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5945716/ https://www.ncbi.nlm.nih.gov/pubmed/29774177 http://dx.doi.org/10.1007/s40472-018-0192-y |
Ejemplares similares
-
Update on Bronchiolitis Obliterans Syndrome in Lung Transplantation
por: Lin, Christine M., et al.
Publicado: (2014) -
Extracorporeal Membrane Oxygenation (ECMO) and the Critical Cardiac Patient
por: Baran, David A.
Publicado: (2017) -
Heart Retransplantation: Candidacy, Outcomes, and Management
por: Barghash, Maya H., et al.
Publicado: (2019) -
Recipient Outcomes with Younger Donors Undergoing Living Donor Liver Transplantation
por: Dar, Faisal S, et al.
Publicado: (2019) -
Effect of kidney donor hepatitis C virus serostatus on renal transplant recipient and allograft outcomes
por: Cohen, Jordana B., et al.
Publicado: (2017)